Search Drug Information, Interactions, Images, Dosage & Side Effects

Brensocatib tackles exacerbations in bronchiectasis 22 Sep 2020

Treatment with the DPP 1* inhibitor brensocatib prolonged time to exacerbation and reduced exacerbation rates in patients with non-cystic fibrosis bronchiectasis, according to the phase II WILLOW** study presented at ERS 2020.

Short-term eGFR changes on SGLT2 inhibitor unrelated to long-term trends

22 Sep 2020

Does nutritional deficiency weaken immune defences against COVID-19?

22 Sep 2020

Pain, self-reported swollen joints tied to flares in rheumatoid arthritis

22 Sep 2020

Take care of our nurses too during pandemic, says study

22 Sep 2020

DHA plus vitamin E supplementation improves sperm motility in men

22 Sep 2020

Masitinib demonstrates potential for severe asthma

22 Sep 2020

COVID-19 disrupts balance of faecal microbiome

22 Sep 2020

Octogenarians suffer from weaker vascular function

22 Sep 2020

Solifenacin improves urinary symptoms but worsens constipation in MS patients with OAB

22 Sep 2020

Incontinence, LUTS impair sexual function, quality of life in older women

22 Sep 2020

How to control asthma well: Experts’ perspectives 21 Sep 2020;
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.

Mepolizumab: Targeting eosinophils in severe asthma with precision medicine

Pearl Toh, 16 Sep 2020

Noninvasive diagnostic tests for NAFLD: Accuracy without the agony

08 Sep 2020

Novel drug delivery system reduces treatment burden in neovascular AMD

Dr. David Eichenbaum, Dr. Dilsher Dhoot, Prof. Peter Campochiaro, Dr. Timothy Y Y Lai, 04 Sep 2020

Soliqua

Contents : Per 100 u/mL + 50 mcg/mL soln for inj (10-40 pen) Insulin glargine 3.64 mg (equiv to 100 u), lixisenatide 50 mcg. Per 100 u/mL + 33 mcg/mL soln for inj (30-60 pen) Insulin glargine 3.64 mg (equiv to 100 u), lixisenatide 33 mcg

Indications/Uses : In combination w/ metformin for adults w/ type 2 DM to improve glycaemic control when metformin alone, or metformin combined w/ another oral glucose lowering drugs, or w/ basal insulin does not provide adequate glycaemic control.

Tationil 600

Contents : Glutathione

Indications/Uses : Adjunct treatment to minimize the occurrence of toxicity associated w/ cisplatin chemotherapy.

Mycozole/Mycozole IV

Contents : Fluconazole

Indications/Uses : Systemic infections including systemic candidiasis, coccidioidomycosis & cryptococcosis; blastomycosis, histoplasmosis & sporotrichosis; fungal skin infections.

Apidra Solostar

Contents : Insulin glulisine

Indications/Uses : Treatment of adults, adolescents & childn ≥6 yr w/ DM, where treatment w/ insulin is required.

Calubia

Contents : Bicalutamide

Indications/Uses : Advanced prostate cancer in combination w/ luteinizing hormone-releasing hormone (LHRH) analogue therapy or surgical castration. Monotherapy or as adjuvant to radical prostatectomy or radiotherapy in patients w/ locally advanced prostate cancer at high risk for disease progression.

Flanax/Flanax Forte

Contents : Naproxen Na

Indications/Uses : Relief of mild to moderately severe pain & fever w/ or w/o accompanying inflammation eg musculoskeletal trauma, post-op pain & post-dental extraction. Relief of pain associated w/ postpartum cramping & dysmenorrhea. Treatment of acute migraine attack.

Humer 150 Isotonic Nasal Spray

Contents : Sea water

Indications/Uses : For daily hygiene of nasal passages, as supportive treatment of ENT pathologies disorders or moisturize the mucosa.

Flagyl

Contents : Metronidazole

Indications/Uses : Amebiasis; urogenital trichomoniasis; non-specific vaginitis; giardiasis. Curative treatment of medico-surgical infections due to susceptible anaerobic pathogens. Prophylaxis against infections caused by susceptible anaerobic pathogens in high risk surgical contexts. Conversion from prophylactic or curative injectable treatment of infections due to susceptible anaerobic pathogens.

Loxeva

Contents : Levofloxacin

Indications/Uses : Treatment of community-acquired pneumonia, UTI including complicated UTI, skin & soft tissue infections. Tab: Treatment of adults >18 yr w/ mild, moderate & severe infections caused by susceptible strains of microorganisms in the following diseases: Nosocomial pneumonia, acute bacterial exacerbation of chronic bronchitis, acute maxillary sinusitis, chronic bacterial prostatitis; mild to moderate uncomplicated skin & skin structure infections, acute pyelonephritis & uncomplicated UTI.

Renvela

Contents : Sevelamer carbonate

Indications/Uses : Control of serum P in patients w/ chronic kidney disease (CKD) on dialysis; hyperphosphatemia in adults receiving hemo- or peritoneal dialysis. Adult CKD patients not on dialysis w/ serum P >1.78 mmol/L (5.5 mg/dL). Powd for susp: Control of serum P in ped patients (>6 yr & BSA of >0.75 m²) w/ CKD.

New Brand

21 New

New Dosage Form

1 New

Renvela

pill identifier

Shape

Form

Color 1

Color 2

Markings

Shape

Form

Color 1

Color 2

Search Drug Information, Images & Medical News | MIMS Philippines

Soliqua

Tationil 600

Mycozole/Mycozole IV

Apidra Solostar

Calubia

Flanax/Flanax Forte

Humer 150 Isotonic Nasal Spray

Flagyl

Loxeva

Renvela

Medolev 125/Medolev 275

Toujeo

Exerta